高验前概率肺栓塞患者的抢先抗凝:指南是否被遵循?
该研究在两家急诊科回顾了3500例连续接受CT肺动脉造影(CTPA)的患者,使用修订版日内瓦评分(RGS)将肺栓塞验前概率分为低(0-3分)、中(4-10分)、高(11-18分)三组。在排除高出血风险及CTPA前已治疗深静脉血栓的患者后,117例高验前概率患者中仅2例(1.7%)接受了抢先抗凝;另有37例(32%)高验前概率患者存在抗凝指征但未接受抢先抗凝。从急诊挂号到CTPA完成的时间不因验前概率不同而异。作者结论为医生很少对高验前概率肺栓塞患者使用抢先抗凝,且未加快高验前概率患者的CTPA检查。
要点
- 在117例高验前概率(RGS 11-18分)肺栓塞患者中,仅2例(1.7%)在CTPA完成前接受了抢先抗凝。
- 37例(32%)高验前概率患者存在预先存在的抗凝指征,但未接受抢先抗凝。
- 从急诊挂号到CTPA完成的时间不因肺栓塞验前概率高低而不同。
- 指南建议高验前概率肺栓塞患者在等待诊断结果期间进行抗凝(抢先抗凝)。
- 研究排除高出血风险及CTPA前已治疗深静脉血栓的患者后进行抢先抗凝分析。
适用人群与场景
- 在两家急诊科连续接受CTPA的3500例患者。
- 排除CTPA先于急诊挂号的3例患者。
- 抢先抗凝分析排除高出血风险患者及CTPA前已治疗深静脉血栓的患者。
诊断标准与关键阈值
- 使用修订版日内瓦评分(RGS)评估肺栓塞验前概率:低概率RGS 0-3分,中概率RGS 4-10分,高概率RGS 11-18分。
- 抢先抗凝定义为在CTPA完成前给予治疗性抗凝。
研究设计与关键结果
- 研究类型为回顾性病历审查,纳入两家急诊科连续接受CTPA的3500例患者,排除3例CTPA先于急诊挂号者,剩余3497例中167例(4.8%)为高验前概率肺栓塞。
- 排除29例高出血风险及21例CTPA前已治疗深静脉血栓者后,117例高验前概率患者中仅2例(1.7%)接受了抢先抗凝。
- 剩余115例高验前概率患者中,37例(32%)存在预先存在的抗凝指征但未接受抢先抗凝。
- 从急诊挂号到CTPA完成的时间不因肺栓塞验前概率不同而异。
证据类型、等级与局限
- 证据类型:回顾性病历审查。
- 局限:原文未报告局限性。
对床旁实践的改变
- 原文结论指出医生很少对高验前概率肺栓塞患者使用抢先抗凝,且未加快高验前概率患者的CTPA检查。
指南或共识出处
- Chest
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Guidelines suggest anticoagulation of patients with high pretest probability of pulmonary embolism (PE) while awaiting diagnostic test results (preemptive anticoagulation). Data relevant to the practice of preemptive anticoagulation are not available.
METHODS: We reviewed 3,500 consecutive patients who underwent CT pulmonary angiography (CTPA) at two EDs. We classified the pretest probability for PE using the revised Geneva Score (RGS) as low (RGS 0-3), intermediate (RGS 4-10), or high (RGS 11-18). We classified patients with a high pretest probability of PE as receiving preemptive anticoagulation if therapeutic anticoagulation was given before CTPA completion. Patients with a high bleeding risk and those receiving treatment for DVT before CTPA were excluded from the preemptive anticoagulation analysis. We compared the time elapsed between ED registration and CTPA completion for patients with a low, intermediate, and high pretest probability for PE.
RESULTS: We excluded three of 3,500 patients because CTPA preceded ED registration. Of the remaining 3,497 patients, 167 (4.8%) had a high pretest probability for PE. After excluding 29 patients for high bleeding risk and 21 patients who were treated for DVT prior to CTPA, only two of 117 patients (1.7%) with a high pretest probability for PE received preemptive anticoagulation. Furthermore, 37 of the remaining 115 patients (32%) with a high pretest probability for PE had a preexisting indication for anticoagulation but did not receive preemptive anticoagulation. The time from ED registration to CTPA completion did not differ based on the pretest probability of PE.
CONCLUSIONS: Physicians rarely use preemptive anticoagulation in patients with a high pretest probability for PE. Clinicians do not expedite CTPA examinations for patients with a high pretest probability for PE.
参考来源
- Willoughby L, Adams DM, Evans RS, et al. Preemptive Anticoagulation in Patients With a High Pretest Probability of Pulmonary Embolism: Are Guidelines Followed? Chest. 2017. PMID: 29154971. doi:10.1016/j.chest.2017.11.007
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。